Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

US Patent 10301380 · Granted May 28, 2019

Estimated economic value: $7,382,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Anti-C1S antibodies and methods of use thereof2025
Gene-edited natural killer cells2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
Anti-complement C1s antibodies and uses thereof2025
Anti-complement C1s antibodies and uses thereof2025